Coronary Artery Bypass Grafting (CABG) in Patients with Immune Thrombocytopenia (ITP): a Community Hospital Experience and Review of the Literature (Scientific Article) (Clinical Report)

Coronary Artery Bypass Grafting (CABG) in Patients with Immune Thrombocytopenia (ITP): a Community Hospital Experience and Review of the Literature (Scientific Article) (Clinical Report)

Introduction Patients undergoing cardiac surgery with cardiopulmonary bypass (CPB) are at risk for microvascular bleeding. The frequency of excessive bleeding with CPB varies according to the definition used. Although a recent analysis indicated that 11% of patients have excessive bleeding after cardiac surgery1, only 5-7% have postoperative blood loss of more than 2 liters over a 24 hour period. (2) Excessive microvascular bleeding can result in re-exploration and prolonged hospitalization. If excessive bleeding is defined as patients who require re-exploration, two large series show that the incidence is between 3.6% and 4.2%. (3,4)

Coronary Artery Bypass Grafting (CABG) in Patients with Immune Thrombocytopenia (ITP): a Community Hospital Experience and Review of the Literature (Scientific Article) (Clinical Report)

Leave a Reply

Your email address will not be published. Required fields are marked *